|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o 4SC AG, of Martinsried, Germany, formed a research collaboration with Solvay Pharmaceuticals GmbH, of Brussels, Belgium, to identify new molecules that bind to a certain illness-relevant target structure. Using a computer-based high-throughput screening technology, 4SC has prepared a selection of active substances that Solvay will examine in biological tests.
o Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, completed its acquisition of privately held Quill Medical Inc., of Research Triangle Park, N.C., including all of its technology and intellectual property, for $40 million in cash plus certain future contingent payments based on product ...